MODERN ASPECTS OF COMMUNITY-ACQUIRED PNEUMONIA IN PATIENTS WITH DIABETES MELLITUS
Clinical importance of the community-acquired pneumonia clinical course and treatment in patients with diabetes mellitus is discussed in this review. Clinical characteristics, immunological parameters, possible drugs regimen, depending on community-acquired pneumonia severity, and the ability to optimize therapy with antibacterial drugs are considered. The features of the appointment of antibacterial drugs in the step-down antibacterial therapy, peculiarities of pneumonia in patients with diabetes mellitus.